Diabetes as a Cause of Urine Colour and Volume Change

How diabetes mellitus changes urine

Diabetes mellitus is a group of conditions characterised by chronically raised blood glucose. The two main types are type 1 (autoimmune destruction of pancreatic beta cells, usually presenting in childhood or young adulthood, requiring insulin) and type 2 (insulin resistance plus relative insulin deficiency, usually associated with obesity and metabolic syndrome). Less common forms include gestational diabetes and various monogenic diabetes (MODY). The NHS diabetes overview covers the spectrum.

When blood glucose rises above the renal threshold (around 10 mmol/L in most adults), the kidneys cannot reabsorb all the filtered glucose, and glucose appears in urine (glycosuria). Glucose in urine acts as an osmotic agent, dragging water with it. The result is large urine volumes (polyuria), pale dilute urine, and dehydration. The body responds with intense thirst (polydipsia). The combination of high urine output, intense thirst, weight loss, and tiredness is the classic new-diabetes presentation.

Glucose in urine sometimes produces a slightly sweet smell. In severe poorly controlled type 1 diabetes (or sometimes type 2 under metabolic stress), the body breaks down fat for fuel and produces ketones, which appear in urine and blood. Ketones in breath produce a fruity or pear-drop smell. Ketones plus high blood glucose plus dehydration plus acidosis is diabetic ketoacidosis (DKA), a medical emergency described in the NHS DKA guidance.

Diagnosing diabetes mellitus

Urine glucose dipsticks are widely available in pharmacies and a positive result is suggestive of diabetes. However, diagnosis requires blood tests. The NICE NG28 type 2 diabetes guideline outlines the standard pathway, which uses HbA1c (glycated haemoglobin), fasting plasma glucose, or oral glucose tolerance test.

Diagnostic thresholds (per WHO criteria):

• -HbA1c: 48 mmol/mol (6.5 %) or above
• -Fasting glucose: 7.0 mmol/L or above
• -Random glucose with symptoms: 11.1 mmol/L or above
• -2-hour OGTT: 11.1 mmol/L or above at 2 hours after 75 g oral glucose

Pre-diabetes (raised but not diabetic-range glucose) is HbA1c 42-47 mmol/mol or fasting glucose 5.5-6.9 mmol/L. The NHS type 2 diabetes diagnosis guidance covers the next steps after a positive screening.

Diabetic ketoacidosis (DKA): a 999 emergency

DKA is the leading acute complication of type 1 diabetes and can occur in type 2 diabetes under stress (severe infection, certain medications including SGLT2 inhibitors, missed insulin). The NHS DKA guidance lists the typical features:

• -High blood sugar (typically above 14 mmol/L)
• -Ketones in blood or urine (positive dipstick)
• -Severe thirst, frequent urination, dehydration
• -Nausea, vomiting, abdominal pain
• -Deep, rapid breathing (Kussmaul respirations)
• -Sweet, fruity, or pear-drop smell on breath
• -Drowsiness, confusion, in severe cases coma

DKA needs urgent IV fluids, IV insulin, electrolyte replacement, and treatment of the underlying trigger (often infection). It is a leading cause of intensive care admission in young people with diabetes. Anyone with type 1 diabetes who develops vomiting plus high blood sugar plus ketones should attend A&E even if they feel they could manage at home, because deterioration can be rapid.

Diabetic kidney disease (nephropathy)

Diabetic kidney disease is the long-term consequence of high blood sugar damaging the glomerular filters. It is now the leading cause of end-stage kidney disease in many countries. The earliest detectable change is increased albumin loss in urine (microalbuminuria), measured by urine albumin-creatinine ratio (ACR). The NICE NG203 chronic kidney disease guideline recommends annual urine ACR for everyone with diabetes for early detection.

As diabetic kidney disease progresses, more protein leaks into urine, eventually producing visible foamy urine. The NIH NIDDK diabetic kidney disease reference covers the staging and treatment. Modern treatment with ACE inhibitors, SGLT2 inhibitors, and tight blood sugar and blood pressure control has substantially slowed progression to kidney failure compared to historical natural history.

Foamy urine in someone with diabetes warrants prompt urine ACR and bloods. See our foamy with swelling page for the broader nephrotic syndrome workup.

Diabetes insipidus (DI): a different condition with a similar name

Diabetes insipidus is a separate condition that despite the name has nothing to do with blood glucose. It is caused by inadequate antidiuretic hormone (ADH/vasopressin) production by the pituitary (cranial DI) or kidney resistance to ADH (nephrogenic DI). Without ADH action, the kidneys cannot concentrate urine, producing very large volumes (often 5-15 litres per day) of very dilute pale urine and intense thirst. The NHS diabetes insipidus guidance describes the typical presentation.

DI is rare. Cranial DI can follow head injury, brain surgery, or pituitary tumours. Nephrogenic DI can be inherited or caused by certain medications (lithium being the leading culprit), high blood calcium, or low blood potassium. The diagnostic test is a water deprivation test under specialist supervision, with measurement of plasma and urine osmolality. Distinguishing DI from psychogenic polydipsia (compulsive water drinking) is part of the workup. Treatment for cranial DI is typically desmopressin (a synthetic form of ADH).

Frequently asked questions